Covidien (NYSE: COV) and Depomed, Inc. (NASDAQ: DEPO) announced that Covidien has licensed worldwide rights from Depomed to utilize Depomed’s ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE